Harmony Historical Balance Sheet

HRMY Stock

USD 33.19 0.16 0.48%

Trend analysis of Harmony Biosciences Holdings balance sheet accounts such as Total Current Liabilities of 99.5 M or Total Stockholder Equity of 692.1 M provides information on Harmony Biosciences' total assets, liabilities, and equity, which is the actual value of Harmony Biosciences to its prevalent stockholders. By breaking down trends over time using Harmony Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Harmony Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Harmony Biosciences is a good buy for the upcoming year.

Harmony Biosciences Inventory

4.12 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Harmony Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Harmony Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Harmony Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Harmony Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Harmony currently owns. An asset can also be divided into two categories, current and non-current.

Harmony Biosciences Balance Sheet Chart

At this time, Harmony Biosciences' Intangible Assets are fairly stable compared to the past year.

Total Assets Other Current Liab Total Current Liabilities Other Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Harmony Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Harmony Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Harmony Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Harmony Biosciences Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Harmony Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Harmony Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, Harmony Biosciences' Intangible Assets are fairly stable compared to the past year.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	73.1M	131.1M	145.1M	86.6M
Total Assets	673.9M	811.4M	999.2M	556.4M

Other Current Liab Total Assets

Harmony Biosciences balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital
Total Assets		0.93	0.94	0.88	0.7	0.92	-0.79	-0.59	0.4	0.8	0.97	0.99	0.92	0.89	0.99	0.7	0.85	0.99	0.71	0.92	0.95	-0.92	0.99	-0.9	0.82	0.96
Other Current Liab	0.93		0.99	0.76	0.61	0.82	-0.77	-0.51	0.24	0.75	0.92	0.93	0.77	0.74	0.92	0.67	0.87	0.88	0.83	0.96	0.89	-0.92	0.91	-0.9	0.69	0.82
Total Current Liabilities	0.94	0.99		0.79	0.59	0.83	-0.76	-0.54	0.3	0.81	0.93	0.95	0.82	0.78	0.93	0.67	0.85	0.89	0.77	0.95	0.89	-0.9	0.93	-0.88	0.68	0.83
Total Stockholder Equity	0.88	0.76	0.79		0.57	0.93	-0.65	-0.84	0.72	0.73	0.86	0.87	0.84	0.97	0.88	0.63	0.66	0.88	0.55	0.74	0.93	-0.73	0.88	-0.78	0.7	0.88
Other Liab	0.7	0.61	0.59	0.57		0.72	-0.72	-0.29	-0.03	0.34	0.73	0.67	0.75	0.48	0.72	0.62	0.8	0.72	0.64	0.74	0.75	-0.81	0.72	-0.83	0.95	0.75
Net Tangible Assets	0.92	0.82	0.83	0.93	0.72		-0.8	-0.67	0.5	0.63	0.91	0.88	0.84	0.9	0.94	0.6	0.77	0.95	0.76	0.83	0.97	-0.83	0.94	-0.93	0.85	0.95
Property Plant And Equipment Net	-0.79	-0.77	-0.76	-0.65	-0.72	-0.8		0.18	-0.03	-0.6	-0.7	-0.81	-0.76	-0.71	-0.75	-0.82	-0.91	-0.8	-0.68	-0.88	-0.84	0.88	-0.77	0.87	-0.85	-0.72
Net Debt	-0.59	-0.51	-0.54	-0.84	-0.29	-0.67	0.18		-0.86	-0.5	-0.67	-0.55	-0.54	-0.72	-0.63	-0.24	-0.27	-0.58	-0.35	-0.39	-0.66	0.38	-0.62	0.48	-0.33	-0.62
Retained Earnings	0.4	0.24	0.3	0.72	-0.03	0.5	-0.03	-0.86		0.52	0.42	0.38	0.44	0.67	0.42	0.03	-0.05	0.41	0.01	0.1	0.42	-0.07	0.42	-0.17	0.09	0.46
Accounts Payable	0.8	0.75	0.81	0.73	0.34	0.63	-0.6	-0.5	0.52		0.73	0.84	0.86	0.78	0.73	0.6	0.58	0.74	0.29	0.7	0.69	-0.64	0.76	-0.54	0.47	0.68
Cash	0.97	0.92	0.93	0.86	0.73	0.91	-0.7	-0.67	0.42	0.73		0.95	0.88	0.82	0.99	0.58	0.8	0.96	0.77	0.89	0.93	-0.88	0.99	-0.9	0.8	0.96
Non Current Assets Total	0.99	0.93	0.95	0.87	0.67	0.88	-0.81	-0.55	0.38	0.84	0.95		0.92	0.89	0.97	0.76	0.86	0.97	0.66	0.93	0.93	-0.92	0.97	-0.87	0.79	0.93
Non Currrent Assets Other	0.92	0.77	0.82	0.84	0.75	0.84	-0.76	-0.54	0.44	0.86	0.88	0.92		0.84	0.89	0.69	0.75	0.91	0.48	0.81	0.87	-0.81	0.91	-0.78	0.84	0.9
Other Assets	0.89	0.74	0.78	0.97	0.48	0.9	-0.71	-0.72	0.67	0.78	0.82	0.89	0.84		0.86	0.68	0.67	0.89	0.49	0.74	0.9	-0.73	0.87	-0.74	0.67	0.87
Cash And Short Term Investments	0.99	0.92	0.93	0.88	0.72	0.94	-0.75	-0.63	0.42	0.73	0.99	0.97	0.89	0.86		0.62	0.82	0.99	0.76	0.9	0.95	-0.9	1.0	-0.92	0.83	0.98
Common Stock Shares Outstanding	0.7	0.67	0.67	0.63	0.62	0.6	-0.82	-0.24	0.03	0.6	0.58	0.76	0.69	0.68	0.62		0.88	0.66	0.41	0.83	0.75	-0.84	0.64	-0.69	0.7	0.59
Non Current Liabilities Total	0.85	0.87	0.85	0.66	0.8	0.77	-0.91	-0.27	-0.05	0.58	0.8	0.86	0.75	0.67	0.82	0.88		0.83	0.76	0.97	0.87	-0.99	0.83	-0.92	0.86	0.77
Other Current Assets	0.99	0.88	0.89	0.88	0.72	0.95	-0.8	-0.58	0.41	0.74	0.96	0.97	0.91	0.89	0.99	0.66	0.83		0.71	0.89	0.95	-0.89	0.99	-0.9	0.86	0.99
Other Stockholder Equity	0.71	0.83	0.77	0.55	0.64	0.76	-0.68	-0.35	0.01	0.29	0.77	0.66	0.48	0.49	0.76	0.41	0.76	0.71		0.79	0.76	-0.78	0.74	-0.9	0.67	0.68
Total Liab	0.92	0.96	0.95	0.74	0.74	0.83	-0.88	-0.39	0.1	0.7	0.89	0.93	0.81	0.74	0.9	0.83	0.97	0.89	0.79		0.92	-0.99	0.9	-0.94	0.82	0.82
Net Invested Capital	0.95	0.89	0.89	0.93	0.75	0.97	-0.84	-0.66	0.42	0.69	0.93	0.93	0.87	0.9	0.95	0.75	0.87	0.95	0.76	0.92		-0.92	0.95	-0.95	0.86	0.93
Property Plant And Equipment Gross	-0.92	-0.92	-0.9	-0.73	-0.81	-0.83	0.88	0.38	-0.07	-0.64	-0.88	-0.92	-0.81	-0.73	-0.9	-0.84	-0.99	-0.89	-0.78	-0.99	-0.92		-0.9	0.94	-0.88	-0.84
Total Current Assets	0.99	0.91	0.93	0.88	0.72	0.94	-0.77	-0.62	0.42	0.76	0.99	0.97	0.91	0.87	1.0	0.64	0.83	0.99	0.74	0.9	0.95	-0.9		-0.91	0.83	0.98
Capital Stock	-0.9	-0.9	-0.88	-0.78	-0.83	-0.93	0.87	0.48	-0.17	-0.54	-0.9	-0.87	-0.78	-0.74	-0.92	-0.69	-0.92	-0.9	-0.9	-0.94	-0.95	0.94	-0.91		-0.89	-0.88
Non Current Liabilities Other	0.82	0.69	0.68	0.7	0.95	0.85	-0.85	-0.33	0.09	0.47	0.8	0.79	0.84	0.67	0.83	0.7	0.86	0.86	0.67	0.82	0.86	-0.88	0.83	-0.89		0.86
Net Working Capital	0.96	0.82	0.83	0.88	0.75	0.95	-0.72	-0.62	0.46	0.68	0.96	0.93	0.9	0.87	0.98	0.59	0.77	0.99	0.68	0.82	0.93	-0.84	0.98	-0.88	0.86

Click cells to compare fundamentals

Harmony Biosciences Account Relationship Matchups

Harmony Biosciences balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	427.1M	433.4M	673.9M	811.4M	999.2M	556.4M
Other Current Liab	132.0M	50.8M	73.1M	131.1M	145.1M	86.6M
Total Current Liabilities	134.5M	53.8M	78.9M	163.8M	175.1M	99.5M
Total Stockholder Equity	97.2M	186.5M	402.8M	467.0M	659.2M	692.1M
Other Liab	450K	1.1M	3.2M	1.5M	1.8M	1.5M
Net Tangible Assets	(495.0M)	(65.2M)	42.6M	241.9M	278.2M	292.1M
Property Plant And Equipment Net	938K	820K	573K	371K	1.3M	784.6K
Net Debt	(34.4M)	(42.3M)	(52.1M)	(118.1M)	(436.8M)	(414.9M)
Retained Earnings	(488.2M)	(453.6M)	(272.1M)	(143.3M)	2.2M	2.3M
Accounts Payable	2.6M	1.0M	3.8M	17.7M	13.7M	7.3M
Cash	228.6M	234.3M	243.8M	311.7M	453.0M	248.2M
Non Current Assets Total	164.2M	149.0M	273.6M	360.4M	419.9M	227.1M
Non Currrent Assets Other	902K	4.3M	3.5M	6.6M	6.2M	3.8M
Other Assets	1.7M	902K	4.3M	87.2M	100.3M	105.3M
Cash And Short Term Investments	228.6M	234.3M	323.1M	353.5M	467.2M	269.4M
Net Receivables	22.2M	34.8M	54.7M	74.1M	83.0M	42.9M
Common Stock Shares Outstanding	56.9M	59.2M	61.1M	60.4M	57.9M	64.2M
Liabilities And Stockholders Equity	427.1M	433.4M	673.9M	811.4M	999.2M	556.4M
Non Current Liabilities Total	195.4M	193.2M	192.1M	180.7M	165.0M	161.1M
Inventory	3.8M	4.4M	4.3M	5.4M	7.2M	4.1M
Other Current Assets	8.3M	10.9M	18.1M	18.1M	21.8M	12.6M
Other Stockholder Equity	1.0B	640.1M	675.1M	610.3M	656.9M	615.8M
Total Liab	329.9M	246.9M	271.0M	344.5M	340.0M	260.6M
Net Invested Capital	291.4M	378.5M	594.5M	660.6M	838.4M	880.3M
Total Current Assets	262.9M	284.4M	400.3M	451.1M	579.3M	329.4M
Non Current Liabilities Other	893K	3.2M	2.5M	2.1M	1.9M	1.7M
Net Working Capital	128.4M	230.7M	321.4M	287.3M	404.2M	229.9M
Property Plant Equipment	1.3M	938K	820K	573K	515.7K	837.9K
Short Long Term Debt Total	194.3M	192.0M	191.6M	193.6M	16.3M	15.4M
Long Term Debt	194.3M	190.0M	189.6M	178.6M	163.0M	185.8M
Accumulated Other Comprehensive Income	(427.1M)	0.0	(151K)	2K	66K	69.3K
Intangible Assets	162.3M	143.9M	161.0M	137.1M	113.3M	144.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harmony Historical Balance Sheet

Harmony Biosciences Inventory

4.12 Million

About Harmony Balance Sheet Analysis

Harmony Biosciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Harmony Biosciences balance sheet Correlations

Harmony Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harmony Biosciences balance sheet Accounts

Also Currently Popular

Additional Tools for Harmony Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Assets Total	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Other Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab

Property Plant And Equipment Gross	- 0.99	Total Liab
Property Plant And Equipment Gross	- 0.99	Non Current Liabilities Total
Capital Stock	- 0.95	Net Invested Capital
Capital Stock	- 0.94	Total Liab
Capital Stock	- 0.93	Net Tangible Assets
Property Plant And Equipment Gross	- 0.92	Net Invested Capital